 | Moderna COVID-19 vaccine (redirect from Spikevax) The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National... 165 KB (13,017 words) - 17:59, 27 April 2024 |
 | company's only commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have... 23 KB (1,818 words) - 19:04, 19 April 2024 |
 | with Moderna for fill-finish, packaging and labeling of its mRNA vaccine, Spikevax, during the COVID-19 pandemic. Founded in 2011, Samsung Biologics built... 10 KB (713 words) - 10:20, 24 March 2024 |
2020. "EMA recommends standard marketing authorizations for Comirnaty and Spikevax COVID-19 vaccines". European Medicines Agency. 16 September 2022. Archived... 192 KB (22,021 words) - 19:29, 15 April 2024 |
which the first authorized were COVID-19 vaccines (such as Comirnaty and Spikevax). mRNA is produced by synthesising a ribonucleic acid (RNA) strand from... 24 KB (2,503 words) - 11:29, 22 February 2024 |
Turkey[unreliable source?] The Moderna COVID-19 vaccine, also known as Spikevax, is an mRNA vaccine produced by the American company Moderna, the U.S.... 318 KB (19,351 words) - 20:00, 21 April 2024 |
 | infection effectiveness Hospitalization effectiveness Mortality effectiveness Spikevax 91.45% 78% 93.46% Comirnaty 80.34% 84.26% 89.83% Sputnik V 78.75% 81.38%... 154 KB (13,880 words) - 13:52, 20 April 2024 |
world. Brand Institute also developed the COVID-19 vaccine brand names Spikevax (Moderna), Vaxzevria (AstraZeneca), and Nuvaxovid (Novavax). Brand Institute's... 10 KB (885 words) - 15:16, 23 April 2024 |
 | States National Institute of Allergy and Infectious Diseases and Moderna (Spikevax) have been rolled out. As of 13 September 2021[update], there were four... 99 KB (8,236 words) - 05:40, 15 April 2024 |
 | 2016. "Myokarditt hos gutter og unge menn kan forekomme oftere etter Spikevax-vaksinen fra Moderna". October 6, 2021. Archived from the original on January... 6 KB (481 words) - 11:22, 11 April 2024 |
 | 2022. "EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines". European Medicines Agency (EMA) (Press release). 16... 236 KB (19,394 words) - 05:58, 20 April 2024 |
 | vaccine Coronavirus RNA COVID-19 Comirnaty Convidecia CoronaVac Covaxin Spikevax Covishield CoviVac Covovax EpiVacCorona Janssen COVID-19 vaccine RBD-Dimer... 34 KB (2,305 words) - 03:06, 24 December 2023 |
 | States National Institute of Allergy and Infectious Diseases and Moderna (Spikevax) have been rolled out. As of 13 September 2021[update], there were four... 235 KB (22,765 words) - 03:21, 19 March 2024 |
| mRNA-1283 Vaccine description Target SARS-CoV-2 Vaccine type mRNA Clinical data Trade names Spikevax Routes of administration Intramuscular... 4 KB (275 words) - 09:58, 30 December 2023 |
announced that it would bring forward the rollout of the bivalent Moderna/Spikevax COVID-19 vaccine three days to 14 October, due to the spike in infections... 62 KB (2,614 words) - 17:07, 2 April 2024 |
 | dead link] "TGA approves booster doses of the Moderna COVID-19 vaccine, SPIKEVAX". 8 December 2021. Archived from the original on 31 December 2021. Retrieved... 178 KB (12,119 words) - 03:08, 8 March 2024 |
 | Sweden phase III clinical trials 18 March 2021 22 March 2021 Moderna Spikevax Moderna United States phase III clinical trials 5 May 2021 9 June 2021... 62 KB (5,790 words) - 01:49, 16 March 2024 |
 | COVID-19 vaccine for youngest kids". CBC News. "Regulatory Decision Summary - Spikevax - Health Canada". Health Canada. Archived from the original on July 16... 166 KB (13,886 words) - 11:39, 30 April 2024 |
Retrieved 14 April 2022. "MHRA approves the Moderna COVID-19 vaccine 'Spikevax' for use in 6 to 11-year olds". Gov.uk. 14 April 2022. Retrieved 14 April... 275 KB (30,526 words) - 01:02, 28 April 2024 |
| arrived in Bulgaria, with 290,880 Comirnaty Original/Omicron BA.1 and 1800 Spikevax Bivalent Original/Omicron BA.1 being delivered. Moderna's vaccine for the... 449 KB (34,069 words) - 23:35, 29 April 2024 |
 | Retrieved 14 April 2022. "MHRA approves the Moderna COVID-19 vaccine 'Spikevax' for use in 6 to 11-year olds". Gov.uk. 14 April 2022. Retrieved 14 April... 177 KB (21,506 words) - 00:38, 5 January 2024 |
COVID-19 vaccine for youngest kids". CBC News. "Regulatory Decision Summary - Spikevax - Health Canada". Health Canada. Archived from the original on 2022-07-16... 150 KB (8,473 words) - 05:20, 15 October 2023 |
 | approval granted 2019). mRNA vaccines: Moderna COVID-19 Vaccine (branded as Spikevax) designed to provide protection against COVID-19 caused by infection with... 78 KB (8,780 words) - 01:21, 19 February 2024 |